CB-839 (telaglenastat)
Telaglenastat is a potent and selective reversible inhibitor of glutaminase activity.
On February 5, 2025, Cornerstone sold all rights to Telaglenastat (CB-839) to Synhale.
Telaglenastat is a potent and selective reversible inhibitor of glutaminase activity.